Further investigations on the alpha 1-adrenoceptor blocking properties of AR-C 239 in rats.
AR-C 239, a new alpha-adrenoceptor blocking drug, appears to act selectively on alpha 1 sites in rats. At peripheral sites, this drug did not change the tachycardia induced by spinal sympathetic outflow stimulation in pithed rats, and did not antagonize the inhibitory effects of clonidine on this preparation. In addition, AR-C 239 showed predominant alpha 1-adrenoceptor blocking properties in the bisected rat vas deferens preparation. AR-C 239 did not prevent or reverse the centrally mediated hypotensive and bradycardic actions induced by clonidine, in intact animals. In conclusion, AR-C 239 seems to be a very useful tool for the characterization of peripheral and central alpha 1-adrenoceptors, in this animal species.
Huchet
A M
AM
Andréjak
M
M
Lucet
B
B
Gautret
B
B
Doursout
M F
MF
Ostermann
G
G
Schmitt
H
H
D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology*; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D003000:Clonidine / Q000494:pharmacology; D003655:Decerebrate State; D004347:Drug Interactions; D004558:Electric Stimulation; D016316:Guanfacine; D006146:Guanidines / Q000494:pharmacology; D006339:Heart Rate / Q000187:drug effects; D066298:In Vitro Techniques; D007546:Isoquinolines / Q000494:pharmacology*; D008297:Male; D009130:Muscle, Smooth / Q000187:drug effects; D010648:Phenylacetates / Q000494:pharmacology; D010879:Piperazines; D051381:Rats; D011919:Rats, Inbred Strains; D011942:Receptors, Adrenergic, alpha; D017981:Receptors, Neurotransmitter / Q000187:drug effects; D014649:Vas Deferens / Q000187:drug effects
D000317:Adrenergic alpha-Antagonists; D006146:Guanidines; D007546:Isoquinolines; D010648:Phenylacetates; D010879:Piperazines; D011942:Receptors, Adrenergic, alpha; D017981:Receptors, Neurotransmitter; D016316:Guanfacine; C032994:AR-C239; D003000:Clonidine